Avril MF., Aamdal S., Grob JJ., Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saiag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y.
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
J Clin Oncol, 22:1118-25, 2004.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15020614

Chaudru V., Chompret A., Bressac-de Paillerets B., the French Familial Melanoma Study Group, Avril M-F., Demenais F.
Influence of genes, nevi and sun-sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
J Natl Cancer Inst, 96: 785-795, 2004.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15150307

Ibrahim el C, Aractingi S, Allory Y, Borrini F, Dupuy A, Duvillard P, Carosella ED, Avril MF, Paul P.
Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Int J Cancer,108:243-50, 2004.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14639610

Kannengiesser C., Avril M-F., Spatz A., Laud K., Lenoir G.M., Bressac-de Paillerets B.
CDKN2A as a uveal and cutaneous melanoma susceptibility gene.
Genes Chromosomes Cancer, 2003, 38: 265-268.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14506702

Gillanders,E.; Hank Juo,S.H.; Holland,E.A.; Jones,M.; Nancarrow,D.; Freas-Lutz,D.; Sood,R.; Park,N.; Faruque,M.; Markey,C.; Kefford,R.F.; Palmer,J.; Bergman,W.; Bishop,D.T.; Tucker,M.A.; Bressac-de Paillerets,B.; Hansson,J.; Stark,M.; Gruis,N.; Bishop,J.N.; Goldstein,A.M.; Bailey-Wilson,J.E.; Mann,G.J.; Hayward,N.; Trent,J.
Localization of a novel melanoma susceptibility locus to 1p22.
Am J Hum Genet, 2003, 73: 301-313.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12844286

Laud K., Kannengiesser C., Avril M-F., Chompret A., Stoppa-Lyonnet D., Desjardins L., Eychene A., Demenais F., French Hereditary Melanoma Study Group, Lenoir, G.M., Bressac-de Paillerets B.
BRAF as a melanoma susceptibility candidate gene?
Cancer Res, 2003, 63:3061-5

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12844286

Fung D.C.Y., Holland E.A., Hayward N.K., Bressac-de Paillerets B., Melanoma Genetics Consortium, Mann G.J.
eMelanoBase: an online locus-specific variant database for familial melanoma.
Hum Mut, 2003, 21:2-7.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12497626

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B.
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
Eur J Hum Genet,11:288-96, 2003.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12700603

Kefford R., Newton-Bishop J., Tucker M., Bressac-de Paillerets B., Bianchi-Scarra G., Bergman W., Goldstein A., Puig S., Mackie R., Elder D., Hansson J., Hayward N., Hogg D., Olsson H. for the Melanoma Genetics Consortium.
Genetic testing for melanoma.
Lancet Oncology, 3: 653-654, 2002.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12424065

Bishop D.T.*, Demenais F.*, Goldstein A.M.* (*These authors contributed equally to this work), Bergman W., Newton Bishop J, Bressac-de Paillerets B., Chompret, A., Ghiorzo P., Gruis N., Hansson J., Harland M., Hayward N., Holland E.A., Mann G.J., Mantelli M., Nancarrow D., Platz A., Tucker M.A., The Melanoma Genetics Consortium.
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
J Natl Cancer Inst, 94, 894-903, 2002.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12072543

Bressac-de Paillerets B., Avril M-F., Chompret A., Demenais F.
Genetic and environmental factors in cutaneous malignant melanoma.
Biochimie, 84, 67-74, 2002.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11900878

Briollais L, Demenais F.
Regressive threshold model for familial analysis of complex diseases with variable age of onset.
Genet Epidemiol,23:375-97,2002.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12432505

Avril MF, Chompret A, Verne-Fourment L, Terrier-Lacombe MJ, Spatz A, Fizazi K, Bressac-de Paillerets B, Demenais F, Theodore C.
Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma.
Melanoma Res,11:117-22, 2001.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11333120

Auroy S., Avril M-F., Chompret A., Pham D., Goldstein A.M., Bianchi-Scarrà G., Frébourg T., Joly P., Spatz A., Rubino C., Demenais F., French Hereditary Melanoma Study Group and Bressac-de Paillerets B.
Sporadic multiple primary melanoma cases : CDKN2A germline mutations with a founder effect.
Genes Chromosomes Cancer, 32: 195-202, 2001.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11579459

Briollais L., Chompret A., Guilloud-Bataille M., Bressac-de Paillerets B., Avril M-F., Demenais F.
Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
Int J Epidemiol., 29:408-15, 2000.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10869311

Ciotti P., Struewing J-P., Mantelli M., Chompret A., Avril M-F., Santi P.L., Tucker P., *Bianchi-Scarra G., *Bressac-de Paillerets B., and *Goldstein A.M. *These authors contributed equally to this work.
A single genetic origin for the G101W mutation in 20 melanoma-prone families.
Am J Hum Genet, 67:311-319, 2000.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10869234

Goldstein AM, Martinez M, Tucker MA, Demenais F.
Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
Cancer Epidemiol Biomarkers Prev, 9:889-94, 2000.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11008905

PDFs

FICHE D’INFORMATION AUX APPARENTES

FICHE D’INFORMATION AUX PATIENTS